Zobrazeno 1 - 10
of 692
pro vyhledávání: '"Nagahiro, Saijo"'
Autor:
Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Kazuko Matsumoto, Yoshihiko Fujita, Hideharu Kimura, Keiichi Aomatsu, Daisuke Tamura, Hiroyasu Kaneda, Kanae Kudo, Kazuko Sakai, Kazuyuki Furuta, Tokuzo Arao, Tomoyuki Nagai
Supplementary Figures 1-5 from Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ac10c120b3fe794e966f736c11be4e
https://doi.org/10.1158/1535-7163.22483866.v1
https://doi.org/10.1158/1535-7163.22483866.v1
Autor:
Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Yoshihiko Fujita, Marco A. De Velasco, Keiichi Aomatsu, Daisuke Tamura, Kazuko Matsumoto, Hiroyasu Kaneda, Kazuko Sakai, Kazuyuki Furuta, Tomoyuki Nagai, Kaoru Tanaka, Tokuzo Arao, Kanae Kudo
Purpose: BIBF 1120 is a potent, orally available triple angiokinase inhibitor that inhibits VEGF receptors (VEGFR) 1, 2, and 3, fibroblast growth factor receptors, and platelet-derived growth factor receptors. This study examined the antitumor effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290335ebbb8795f2dc515fa7a390aef8
https://doi.org/10.1158/1078-0432.c.6519036
https://doi.org/10.1158/1078-0432.c.6519036
Autor:
Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Kazuko Matsumoto, Yoshihiko Fujita, Hideharu Kimura, Keiichi Aomatsu, Daisuke Tamura, Hiroyasu Kaneda, Kanae Kudo, Kazuko Sakai, Kazuyuki Furuta, Tokuzo Arao, Tomoyuki Nagai
Supplementary Figure Legends from Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e804f6c9095821d1f1710d28769d498
https://doi.org/10.1158/1535-7163.22483869.v1
https://doi.org/10.1158/1535-7163.22483869.v1
Autor:
Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Yoshihiko Fujita, Marco A. De Velasco, Keiichi Aomatsu, Daisuke Tamura, Kazuko Matsumoto, Hiroyasu Kaneda, Kazuko Sakai, Kazuyuki Furuta, Tomoyuki Nagai, Kaoru Tanaka, Tokuzo Arao, Kanae Kudo
Supplementary Figures S1-S3; Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8657c33cceff5c7b0f45864c4b0c6fa
https://doi.org/10.1158/1078-0432.22442247.v1
https://doi.org/10.1158/1078-0432.22442247.v1
Autor:
Kazuto Nishio, Masatoshi Kudo, Nagahiro Saijo, Kazuko Matsumoto, Yoshihiko Fujita, Hideharu Kimura, Keiichi Aomatsu, Daisuke Tamura, Hiroyasu Kaneda, Kanae Kudo, Kazuko Sakai, Kazuyuki Furuta, Tokuzo Arao, Tomoyuki Nagai
The epithelial mesenchymal transition (EMT) has emerged as a pivotal event in the development of the invasive and metastatic potentials of cancer progression. Sorafenib, a VEGFR inhibitor with activity against RAF kinase, is active against hepatocell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0b0dbeeb12e6494284443439bd9304
https://doi.org/10.1158/1535-7163.c.6531258
https://doi.org/10.1158/1535-7163.c.6531258
Autor:
Kazuto Nishio, Nagahiro Saijo, Yasuhide Yamada, Tomohide Tamura, Keiichi Aomatsu, Daisuke Tamura, Yoshihiko Fujita, Kanae Kudo, Hiroyasu Kaneda, Kaoru Tanaka, Tokuzo Arao, Kazuko Matsumoto
Supplementary Figure Legends 1-2 from mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a6373e4b79731873589e72af05bbc5
https://doi.org/10.1158/0008-5472.22379360.v1
https://doi.org/10.1158/0008-5472.22379360.v1
Autor:
Kazuto Nishio, Nagahiro Saijo, Yasuhide Yamada, Tomohide Tamura, Keiichi Aomatsu, Daisuke Tamura, Yoshihiko Fujita, Kanae Kudo, Hiroyasu Kaneda, Kaoru Tanaka, Tokuzo Arao, Kazuko Matsumoto
Supplementary Figures 1-2 from mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487784b59a07086b58ea2a06c1d83161
https://doi.org/10.1158/0008-5472.22379357
https://doi.org/10.1158/0008-5472.22379357
Autor:
Kazuto Nishio, Nagahiro Saijo, Yasuhide Yamada, Tomohide Tamura, Keiichi Aomatsu, Daisuke Tamura, Yoshihiko Fujita, Kanae Kudo, Hiroyasu Kaneda, Kaoru Tanaka, Tokuzo Arao, Kazuko Matsumoto
The underlying mechanism regulating the expression of the cancer stem cell/tumor-initiating cell marker CD133/prominin-1 in cancer cells remains largely unclear, although knowledge of this mechanism would likely provide important biological informati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c45f14699e89ba6dbad8d72f941871a9
https://doi.org/10.1158/0008-5472.c.6499229.v1
https://doi.org/10.1158/0008-5472.c.6499229.v1
Autor:
Nagahiro Saijo, Yoshiyuki Shibasaki, Yutaka Endo, Mototsugu Oya, Akihiko Gemma, Yasuharu Toyoshima, Hideyuki Akaza, Kazuo Sato, Shigeru Sugiyama, Naoto Miyanaga, Taku Uryu
Publikováno v:
Japanese Journal of Clinical Oncology
Objective A prospective, observational, post-marketing surveillance was conducted to assess the safety and effectiveness of temsirolimus in patients with renal cell carcinoma in Japan. Methods Patients prescribed temsirolimus for advanced renal cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08112f882beca1194394e4baf7d9e752
https://doi.org/10.1093/jjco/hyaa062
https://doi.org/10.1093/jjco/hyaa062
Autor:
Hiro Takahashi, Kimie Sai, Yoshiro Saito, Nahoko Kaniwa, Yasuhiro Matsumura, Tetsuya Hamaguchi, Yasuhiro Shimada, Atsushi Ohtsu, Takayuki Yoshino, Toshihiko Doi, Haruhiro Okuda, Risa Ichinohe, Anna Takahashi, Ayano Doi, Yoko Odaka, Misuzu Okuyama, Nagahiro Saijo, Jun-ichi Sawada, Hiromi Sakamoto, Teruhiko Yoshida
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105160 (2014)
Interindividual variation in a drug response among patients is known to cause serious problems in medicine. Genomic information has been proposed as the basis for "personalized" health care. The genome-wide association study (GWAS) is a powerful tech
Externí odkaz:
https://doaj.org/article/c1db012794544cb3b3b8b0dc8cff9f2d